
Loading, please wait...

Loading, please wait...

Ghana recently joined other African nations in declining a major health partnership with the United States. This decision highlights growing health data privacy concerns across the continent. According to officials, the proposed deal lacked sufficient safeguards for sensitive citizen information. Consequently, Ghana has prioritized national data sovereignty over significant foreign funding.
The proposed agreement was worth approximately $300 million over five years. However, the Ghanaian Data Protection Commission identified several legal and ethical breaches. Specifically, the deal would have granted up to 10 US entities access to national health datasets. Furthermore, these entities would not have needed prior approval from the Ghanaian government. Instead, the US would simply notify the country after data utilization. Therefore, officials argued that this arrangement effectively outsourced the nation's health architecture. Moreover, the scope of access extended beyond raw data to include dashboards and data models.
Ghana is the latest country to walk away from the \"America First\" global health funding model. For instance, Zimbabwe rejected a similar proposal earlier this year. Zambia is also currently reviewing sections of its draft agreement with significant skepticism. Activists claim these deals often lack adequate protections for pathogen and genomic information. Additionally, some agreements are viewed as overly restrictive regarding which healthcare providers receive support. As a result, the Africa CDC has expressed major concerns regarding international data sharing. Ghana now seeks improved terms that respect local governance and citizen privacy.
Q1: Why did Ghana reject the US health agreement?
Ghana rejected the deal primarily due to health data privacy concerns. The agreement would have allowed foreign access to sensitive data without adequate local oversight or prior approval.
Q2: How much funding was involved in the rejected Ghana-US deal?
The deal was worth about $300 million total. It included $109 million in direct US funding over five years to fight diseases like malaria and HIV/AIDS.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Ghana joins Zimbabwe in rejecting a US health deal due to health data privacy concerns and lack of oversight regarding sensitive citizen information....
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today